<?xml-stylesheet type="text/xsl" href="varreports_v3.xsl"?><data_table name="lipids1_5s" dataset_id="pht000205.v7" study_name="Framingham Cohort" study_id="phs000007.v30" participant_set="11" date_created="2018/09/17"><description>Lipid Traits (fractions, particles, size, etc), Offspring Cohort Exams 4, 5</description><variable id="phv00024707.v6.p11" var_name="shareid" calculated_type="string" reported_type=""><description>UNIQUE PARTICIPANT ID</description><total><subject_profile><sex><male>1951</male><female>2115</female></sex></subject_profile><stats><stat n="4066" nulls="0"/></stats></total></variable><variable id="phv00024707.v6.p11.c1" var_name="shareid" calculated_type="string" reported_type=""><description>UNIQUE PARTICIPANT ID</description><total><subject_profile><sex><male>1506</male><female>1624</female></sex></subject_profile><stats><stat n="3130" nulls="0"/></stats></total></variable><variable id="phv00024707.v6.p11.c2" var_name="shareid" calculated_type="string" reported_type=""><description>UNIQUE PARTICIPANT ID</description><total><subject_profile><sex><male>438</male><female>486</female></sex></subject_profile><stats><stat n="924" nulls="0"/></stats></total></variable><variable id="phv00024681.v6.p11" var_name="IDTYPE" calculated_type="enum_integer" reported_type=""><description>COHORT IDENTIFIER</description><total><subject_profile><sex><male>1951</male><female>2115</female></sex></subject_profile><stats><stat n="4066" nulls="0" mean_count="4066" median_count="4066" min_count="4066" max_count="4066"/><enum code="1" count="4066">OFFSPRING GROUP</enum></stats></total></variable><variable id="phv00024681.v6.p11.c1" var_name="IDTYPE" calculated_type="enum_integer" reported_type=""><description>COHORT IDENTIFIER</description><total><subject_profile><sex><male>1506</male><female>1624</female></sex></subject_profile><stats><stat n="3130" nulls="0" mean_count="3130" median_count="3130" min_count="3130" max_count="3130"/><enum code="1" count="3130">OFFSPRING GROUP</enum></stats></total></variable><variable id="phv00024681.v6.p11.c2" var_name="IDTYPE" calculated_type="enum_integer" reported_type=""><description>COHORT IDENTIFIER</description><total><subject_profile><sex><male>438</male><female>486</female></sex></subject_profile><stats><stat n="924" nulls="0" mean_count="924" median_count="924" min_count="924" max_count="924"/><enum code="1" count="924">OFFSPRING GROUP</enum></stats></total></variable><variable id="phv00024682.v6.p11" var_name="CHYLO" calculated_type="decimal" units="MG/DL" reported_type=""><description>CHYLOMICRON PARTICLES SIZE &gt; 220 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="1.239" sd="1.805" median="0.7" min="0" max="24.7"/><example count="790">0</example><example count="199">0.1</example><example count="153">0.4</example><example count="136">0.2</example><example count="132">0.3</example><example count="124">0.5</example><example count="123">0.6</example><example count="119">0.7</example><example count="115">0.9</example><example count="103">0.8</example></stats></total></variable><variable id="phv00024682.v6.p11.c1" var_name="CHYLO" calculated_type="decimal" units="MG/DL" reported_type=""><description>CHYLOMICRON PARTICLES SIZE &gt; 220 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="1.22" sd="1.714" median="0.7" min="0" max="24.7"/><example count="612">0</example><example count="149">0.1</example><example count="115">0.4</example><example count="104">0.2</example><example count="102">0.3</example><example count="102">0.6</example><example count="95">0.5</example><example count="93">0.9</example><example count="87">0.7</example><example count="80">0.8</example></stats></total></variable><variable id="phv00024682.v6.p11.c2" var_name="CHYLO" calculated_type="decimal" units="MG/DL" reported_type=""><description>CHYLOMICRON PARTICLES SIZE &gt; 220 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="1.319" sd="2.092" median="0.7" min="0" max="22.1"/><example count="174">0</example><example count="48">0.1</example><example count="38">0.4</example><example count="31">0.2</example><example count="31">0.7</example><example count="30">0.3</example><example count="27">0.5</example><example count="24">1</example><example count="22">0.8</example><example count="22">0.9</example></stats></total></variable><variable id="phv00024683.v6.p11" var_name="VLDLP6" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 150+/-70 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="8.97" sd="19.76" median="2.7" min="0" max="343.1"/><example count="394">0</example><example count="87">0.1</example><example count="70">0.3</example><example count="68">0.2</example><example count="61">0.5</example><example count="57">1.1</example><example count="56">0.6</example><example count="55">1.5</example><example count="54">0.8</example><example count="52">0.7</example></stats></total></variable><variable id="phv00024683.v6.p11.c1" var_name="VLDLP6" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 150+/-70 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="8.519" sd="19.26" median="2.6" min="0" max="343.1"/><example count="325">0</example><example count="77">0.1</example><example count="58">0.3</example><example count="56">0.2</example><example count="49">0.5</example><example count="48">1.5</example><example count="47">0.6</example><example count="44">0.9</example><example count="43">0.8</example><example count="43">1.1</example></stats></total></variable><variable id="phv00024683.v6.p11.c2" var_name="VLDLP6" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 150+/-70 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="10.52" sd="21.43" median="3.3" min="0" max="277.1"/><example count="69">0</example><example count="16">2.2</example><example count="15">1.3</example><example count="15">0.4</example><example count="14">1</example><example count="14">1.1</example><example count="13">1.7</example><example count="12">0.2</example><example count="12">1.8</example><example count="12">0.3</example></stats></total></variable><variable id="phv00024684.v6.p11" var_name="VLDLP5" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 70+/-10 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="21.52" sd="33.55" median="7.1" min="0" max="373.3"/><example count="475">0</example><example count="90">0.1</example><example count="71">0.2</example><example count="54">0.3</example><example count="54">0.4</example><example count="42">0.7</example><example count="42">0.5</example><example count="41">0.6</example><example count="36">0.9</example><example count="34">0.8</example></stats></total></variable><variable id="phv00024684.v6.p11.c1" var_name="VLDLP5" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 70+/-10 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="20.61" sd="33.13" median="6.3" min="0" max="373.3"/><example count="393">0</example><example count="74">0.1</example><example count="57">0.2</example><example count="44">0.3</example><example count="36">0.4</example><example count="32">0.6</example><example count="32">0.7</example><example count="32">0.5</example><example count="31">0.9</example><example count="26">1</example></stats></total></variable><variable id="phv00024684.v6.p11.c2" var_name="VLDLP5" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 70+/-10 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="24.65" sd="34.97" median="10.2" min="0" max="261.6"/><example count="82">0</example><example count="18">0.4</example><example count="16">0.1</example><example count="13">0.2</example><example count="10">0.3</example><example count="10">1.3</example><example count="10">0.7</example><example count="10">0.5</example><example count="9">0.8</example><example count="9">0.6</example></stats></total></variable><variable id="phv00024685.v6.p11" var_name="VLDLP4" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 50+/-10 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="21.33" sd="17.4" median="16.8" min="0" max="181.8"/><example count="20">9.7</example><example count="20">9.9</example><example count="20">8.4</example><example count="20">14.4</example><example count="19">10.1</example><example count="19">8.8</example><example count="18">0</example><example count="17">13.2</example><example count="17">14.3</example><example count="17">12.1</example></stats></total></variable><variable id="phv00024685.v6.p11.c1" var_name="VLDLP4" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 50+/-10 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="21.01" sd="17.43" median="16.5" min="0" max="181.8"/><example count="18">9.7</example><example count="18">8.4</example><example count="15">14.3</example><example count="15">8.1</example><example count="15">10.1</example><example count="14">0</example><example count="14">12.1</example><example count="14">10.6</example><example count="14">9.9</example><example count="14">8.8</example></stats></total></variable><variable id="phv00024685.v6.p11.c2" var_name="VLDLP4" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 50+/-10 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="22.43" sd="17.29" median="17.7" min="0" max="135.5"/><example count="8">12.8</example><example count="8">7</example><example count="8">8.6</example><example count="8">14.4</example><example count="6">17.1</example><example count="6">16.3</example><example count="6">9.4</example><example count="6">9.9</example><example count="6">7.4</example><example count="5">1.8</example></stats></total></variable><variable id="phv00024686.v6.p11" var_name="VLDLP3" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 38+/-3 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="21.48" sd="19.06" median="16.8" min="0" max="218.7"/><example count="77">0</example><example count="19">3.3</example><example count="18">7.9</example><example count="18">3.9</example><example count="17">2.5</example><example count="17">19.2</example><example count="17">6</example><example count="17">12.6</example><example count="17">8.4</example><example count="16">4.5</example></stats></total></variable><variable id="phv00024686.v6.p11.c1" var_name="VLDLP3" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 38+/-3 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="21" sd="18.91" median="16.3" min="0" max="218.7"/><example count="70">0</example><example count="17">3.9</example><example count="14">2.5</example><example count="14">4.5</example><example count="14">19.2</example><example count="14">8.4</example><example count="14">7.9</example><example count="14">9.8</example><example count="13">3.3</example><example count="13">8.3</example></stats></total></variable><variable id="phv00024686.v6.p11.c2" var_name="VLDLP3" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 38+/-3 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="22.95" sd="19.33" median="18.5" min="0" max="165.1"/><example count="7">0</example><example count="7">7.7</example><example count="6">3.3</example><example count="6">3.5</example><example count="6">26</example><example count="6">13</example><example count="5">24.6</example><example count="5">14.5</example><example count="5">13.2</example><example count="5">5</example></stats></total></variable><variable id="phv00024687.v6.p11" var_name="VLDLP2" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 33+/-2 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="16.62" sd="13.21" median="14.8" min="0" max="107.7"/><example count="213">0</example><example count="23">0.6</example><example count="23">0.4</example><example count="20">0.8</example><example count="20">0.1</example><example count="18">1.7</example><example count="18">12.3</example><example count="17">9.9</example><example count="17">1.5</example><example count="16">10.7</example></stats></total></variable><variable id="phv00024687.v6.p11.c1" var_name="VLDLP2" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 33+/-2 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="16.45" sd="13.09" median="14.3" min="0" max="107.7"/><example count="168">0</example><example count="20">0.6</example><example count="16">0.4</example><example count="15">11.7</example><example count="14">0.2</example><example count="14">10.7</example><example count="14">0.8</example><example count="14">0.1</example><example count="14">1.7</example><example count="14">18.4</example></stats></total></variable><variable id="phv00024687.v6.p11.c2" var_name="VLDLP2" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 33+/-2 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="17.14" sd="13.47" median="15.9" min="0" max="73.4"/><example count="43">0</example><example count="7">9.9</example><example count="7">0.4</example><example count="6">0.8</example><example count="6">0.1</example><example count="6">17.7</example><example count="6">12.3</example><example count="6">8.9</example><example count="5">24.6</example><example count="5">22.3</example></stats></total></variable><variable id="phv00024688.v6.p11" var_name="VLDLP1" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 29+/-2 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="4.769" sd="4.982" median="3.3" min="0" max="28.5"/><example count="542">0</example><example count="67">0.2</example><example count="64">0.3</example><example count="57">0.1</example><example count="50">0.5</example><example count="49">0.4</example><example count="45">0.6</example><example count="42">1.8</example><example count="41">1.6</example><example count="40">1</example></stats></total></variable><variable id="phv00024688.v6.p11.c1" var_name="VLDLP1" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 29+/-2 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="4.79" sd="4.937" median="3.3" min="0" max="27.7"/><example count="419">0</example><example count="53">0.3</example><example count="43">0.2</example><example count="39">0.4</example><example count="37">1.6</example><example count="37">0.1</example><example count="35">1.8</example><example count="35">0.6</example><example count="31">0.5</example><example count="30">1.7</example></stats></total></variable><variable id="phv00024688.v6.p11.c2" var_name="VLDLP1" calculated_type="decimal" units="MG/DL" reported_type=""><description>VLDL PARTICLES SIZE 29+/-2 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="4.682" sd="5.132" median="3.3" min="0" max="28.5"/><example count="122">0</example><example count="23">0.2</example><example count="20">0.1</example><example count="19">0.5</example><example count="12">1</example><example count="12">3.6</example><example count="11">0.3</example><example count="11">0.7</example><example count="10">3.3</example><example count="10">5.8</example></stats></total></variable><variable id="phv00024689.v6.p11" var_name="IDLP" calculated_type="decimal" units="MG/DL" reported_type=""><description>IDL PARTICLES 25+/-2 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="4.903" sd="5.346" median="3.2" min="0" max="41"/><example count="600">0</example><example count="57">0.3</example><example count="55">0.2</example><example count="53">0.1</example><example count="47">0.7</example><example count="45">0.6</example><example count="44">2.6</example><example count="42">1.7</example><example count="42">0.4</example><example count="41">0.9</example></stats></total></variable><variable id="phv00024689.v6.p11.c1" var_name="IDLP" calculated_type="decimal" units="MG/DL" reported_type=""><description>IDL PARTICLES 25+/-2 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="4.67" sd="5.198" median="3.1" min="0" max="41"/><example count="501">0</example><example count="49">0.3</example><example count="40">0.1</example><example count="39">0.2</example><example count="37">0.6</example><example count="34">1.7</example><example count="33">2.6</example><example count="33">0.5</example><example count="32">0.7</example><example count="32">0.9</example></stats></total></variable><variable id="phv00024689.v6.p11.c2" var_name="IDLP" calculated_type="decimal" units="MG/DL" reported_type=""><description>IDL PARTICLES 25+/-2 NM (EXPRESSED AS TG CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="5.647" sd="5.692" median="3.9" min="0" max="27.7"/><example count="97">0</example><example count="15">0.2</example><example count="15">0.7</example><example count="13">2.8</example><example count="13">0.1</example><example count="12">1.9</example><example count="11">2.6</example><example count="11">3.5</example><example count="11">0.4</example><example count="11">2.4</example></stats></total></variable><variable id="phv00024690.v6.p11" var_name="LDLP3" calculated_type="decimal" units="MG/DL" reported_type=""><description>LDL PARTICLES 22+/-0.7 NM
 (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="71.29" sd="35.85" median="71.7" min="0" max="280.2"/><example count="54">0</example><example count="14">67.3</example><example count="10">81.7</example><example count="10">73.8</example><example count="10">59.9</example><example count="9">94.3</example><example count="9">74.5</example><example count="9">77.8</example><example count="8">98.1</example><example count="8">60.1</example></stats></total></variable><variable id="phv00024690.v6.p11.c1" var_name="LDLP3" calculated_type="decimal" units="MG/DL" reported_type=""><description>LDL PARTICLES 22+/-0.7 NM
 (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="71.28" sd="35.1" median="71.6" min="0" max="190.1"/><example count="39">0</example><example count="11">67.3</example><example count="9">94.3</example><example count="9">81.7</example><example count="9">74.5</example><example count="9">77.8</example><example count="8">59.9</example><example count="8">76.2</example><example count="8">85.5</example><example count="7">98.1</example></stats></total></variable><variable id="phv00024690.v6.p11.c2" var_name="LDLP3" calculated_type="decimal" units="MG/DL" reported_type=""><description>LDL PARTICLES 22+/-0.7 NM
 (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="71.38" sd="38.31" median="72" min="0" max="280.2"/><example count="14">0</example><example count="5">73.8</example><example count="4">90</example><example count="4">89.1</example><example count="4">96.1</example><example count="3">108.7</example><example count="3">69.6</example><example count="3">86.7</example><example count="3">80.3</example><example count="3">79.9</example></stats></total></variable><variable id="phv00024691.v6.p11" var_name="LDLP2" calculated_type="decimal" units="MG/DL" reported_type=""><description>LDL PARTICLES 20.5+/-0.7 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="34.26" sd="24.82" median="29.2" min="0" max="174.3"/><example count="63">0</example><example count="13">12</example><example count="12">17.7</example><example count="12">29.2</example><example count="12">17.5</example><example count="11">27.8</example><example count="11">15</example><example count="11">22.3</example><example count="11">9.3</example><example count="11">12.1</example></stats></total></variable><variable id="phv00024691.v6.p11.c1" var_name="LDLP2" calculated_type="decimal" units="MG/DL" reported_type=""><description>LDL PARTICLES 20.5+/-0.7 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="33.12" sd="24.73" median="28.2" min="0" max="174.3"/><example count="57">0</example><example count="10">9.3</example><example count="10">17.7</example><example count="10">12.1</example><example count="10">18.9</example><example count="9">29.4</example><example count="9">15</example><example count="9">13.2</example><example count="9">16.6</example><example count="9">12</example></stats></total></variable><variable id="phv00024691.v6.p11.c2" var_name="LDLP2" calculated_type="decimal" units="MG/DL" reported_type=""><description>LDL PARTICLES 20.5+/-0.7 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="37.92" sd="24.51" median="32.6" min="0" max="140.2"/><example count="6">0</example><example count="6">34.4</example><example count="5">18.6</example><example count="5">42.3</example><example count="5">17.3</example><example count="5">17</example><example count="4">27.8</example><example count="4">16.1</example><example count="4">45.3</example><example count="4">38.1</example></stats></total></variable><variable id="phv00024692.v6.p11" var_name="LDLP1" calculated_type="decimal" units="MG/DL" reported_type=""><description>LDL PARTICLES 19+/-0.7 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="27.21" sd="25.73" median="19.7" min="0" max="176.6"/><example count="99">0</example><example count="18">13.6</example><example count="17">11.6</example><example count="17">2.2</example><example count="16">9.4</example><example count="16">16.9</example><example count="15">22</example><example count="15">9.2</example><example count="14">12.6</example><example count="14">13.1</example></stats></total></variable><variable id="phv00024692.v6.p11.c1" var_name="LDLP1" calculated_type="decimal" units="MG/DL" reported_type=""><description>LDL PARTICLES 19+/-0.7 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="27.12" sd="25.56" median="19.5" min="0" max="154"/><example count="78">0</example><example count="16">13.6</example><example count="14">22</example><example count="14">16.9</example><example count="13">11.6</example><example count="13">15.4</example><example count="11">9.4</example><example count="11">15.9</example><example count="11">13.1</example><example count="11">23.6</example></stats></total></variable><variable id="phv00024692.v6.p11.c2" var_name="LDLP1" calculated_type="decimal" units="MG/DL" reported_type=""><description>LDL PARTICLES 19+/-0.7 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="27.51" sd="26.27" median="20" min="0" max="176.6"/><example count="21">0</example><example count="7">20.2</example><example count="6">2.2</example><example count="6">19.1</example><example count="5">47.2</example><example count="5">9.4</example><example count="5">15.7</example><example count="5">12.6</example><example count="5">2.7</example><example count="5">17</example></stats></total></variable><variable id="phv00024693.v6.p11" var_name="HDLP5" calculated_type="decimal" units="MG/DL" reported_type=""><description>HDL PARTICLES 11.5+/-1.5 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="10.29" sd="7.01" median="8.4" min="0" max="55.9"/><example count="44">6.1</example><example count="40">6.9</example><example count="40">5.7</example><example count="39">6.2</example><example count="38">5.5</example><example count="38">8.3</example><example count="37">5.4</example><example count="37">7.7</example><example count="37">5.1</example><example count="35">4.6</example></stats></total></variable><variable id="phv00024693.v6.p11.c1" var_name="HDLP5" calculated_type="decimal" units="MG/DL" reported_type=""><description>HDL PARTICLES 11.5+/-1.5 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="10.33" sd="6.979" median="8.4" min="0" max="55.9"/><example count="37">6.1</example><example count="35">5.7</example><example count="34">6.9</example><example count="33">6.2</example><example count="30">9.3</example><example count="30">7.7</example><example count="29">5.5</example><example count="28">5.4</example><example count="28">6.6</example><example count="27">7.9</example></stats></total></variable><variable id="phv00024693.v6.p11.c2" var_name="HDLP5" calculated_type="decimal" units="MG/DL" reported_type=""><description>HDL PARTICLES 11.5+/-1.5 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="10.14" sd="7.154" median="8.3" min="0" max="53.6"/><example count="12">4.6</example><example count="12">8.3</example><example count="12">5.1</example><example count="12">7.4</example><example count="11">8.9</example><example count="10">5.2</example><example count="10">6.8</example><example count="9">5.5</example><example count="9">5.4</example><example count="9">6.3</example></stats></total></variable><variable id="phv00024694.v6.p11" var_name="HDLP4" calculated_type="decimal" units="MG/DL" reported_type=""><description>HDL PARTICLES 9.4+/-0.6 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="12.28" sd="10.82" median="10.6" min="0" max="63.7"/><example count="546">0</example><example count="37">0.1</example><example count="24">0.2</example><example count="24">0.6</example><example count="23">0.3</example><example count="21">9.4</example><example count="20">2.6</example><example count="19">1.4</example><example count="19">0.5</example><example count="19">0.4</example></stats></total></variable><variable id="phv00024694.v6.p11.c1" var_name="HDLP4" calculated_type="decimal" units="MG/DL" reported_type=""><description>HDL PARTICLES 9.4+/-0.6 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="12.48" sd="10.89" median="10.8" min="0" max="62.3"/><example count="413">0</example><example count="29">0.1</example><example count="22">0.3</example><example count="19">0.2</example><example count="16">9.4</example><example count="15">0.6</example><example count="15">1.4</example><example count="14">9.9</example><example count="14">3.9</example><example count="14">4.7</example></stats></total></variable><variable id="phv00024694.v6.p11.c2" var_name="HDLP4" calculated_type="decimal" units="MG/DL" reported_type=""><description>HDL PARTICLES 9.4+/-0.6 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="11.68" sd="10.59" median="9.7" min="0" max="63.7"/><example count="130">0</example><example count="9">0.6</example><example count="8">0.1</example><example count="8">2.6</example><example count="6">1.3</example><example count="6">0.5</example><example count="6">17.6</example><example count="6">0.4</example><example count="6">10.5</example><example count="5">0.2</example></stats></total></variable><variable id="phv00024695.v6.p11" var_name="HDLP3" calculated_type="decimal" units="MG/DL" reported_type=""><description>HDL PARTICLES 8.5+/-0.3 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="10.29" sd="5.771" median="10" min="0" max="36.5"/><example count="102">0</example><example count="40">8.9</example><example count="37">10.6</example><example count="34">8</example><example count="33">9.9</example><example count="33">8.6</example><example count="32">7.8</example><example count="32">10.3</example><example count="32">11.8</example><example count="31">9.1</example></stats></total></variable><variable id="phv00024695.v6.p11.c1" var_name="HDLP3" calculated_type="decimal" units="MG/DL" reported_type=""><description>HDL PARTICLES 8.5+/-0.3 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="10.03" sd="5.732" median="9.8" min="0" max="36.5"/><example count="85">0</example><example count="31">10.6</example><example count="31">8.9</example><example count="26">7.8</example><example count="24">11.7</example><example count="24">8</example><example count="24">9.1</example><example count="24">8.5</example><example count="24">12.3</example><example count="23">10.2</example></stats></total></variable><variable id="phv00024695.v6.p11.c2" var_name="HDLP3" calculated_type="decimal" units="MG/DL" reported_type=""><description>HDL PARTICLES 8.5+/-0.3 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="11.12" sd="5.792" median="10.7" min="0" max="34"/><example count="17">0</example><example count="12">9.4</example><example count="12">11.8</example><example count="11">12.4</example><example count="10">8</example><example count="10">9.9</example><example count="10">8.6</example><example count="10">9.6</example><example count="9">10.9</example><example count="9">10.3</example></stats></total></variable><variable id="phv00024696.v6.p11" var_name="HDLP2" calculated_type="decimal" units="MG/DL" reported_type=""><description>HDL PARTICLES 8.0+/-0.2 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="10.72" sd="5.99" median="10.6" min="0" max="34.4"/><example count="118">0</example><example count="31">11.8</example><example count="30">7</example><example count="29">12.4</example><example count="28">9.3</example><example count="28">10.6</example><example count="27">14.2</example><example count="27">11.9</example><example count="26">11.4</example><example count="26">12</example></stats></total></variable><variable id="phv00024696.v6.p11.c1" var_name="HDLP2" calculated_type="decimal" units="MG/DL" reported_type=""><description>HDL PARTICLES 8.0+/-0.2 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="10.88" sd="6.054" median="10.8" min="0" max="34.4"/><example count="78">0</example><example count="26">7</example><example count="26">11.8</example><example count="24">12.4</example><example count="22">10.6</example><example count="21">11.4</example><example count="21">9.3</example><example count="21">8.5</example><example count="21">10.8</example><example count="20">8.2</example></stats></total></variable><variable id="phv00024696.v6.p11.c2" var_name="HDLP2" calculated_type="decimal" units="MG/DL" reported_type=""><description>HDL PARTICLES 8.0+/-0.2 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="10.18" sd="5.716" median="10.4" min="0" max="28.7"/><example count="39">0</example><example count="12">10.4</example><example count="11">4.9</example><example count="9">15.2</example><example count="9">12</example><example count="9">15.8</example><example count="8">10.7</example><example count="8">5.3</example><example count="8">7.1</example><example count="8">14.2</example></stats></total></variable><variable id="phv00024697.v6.p11" var_name="HDLP1" calculated_type="decimal" units="MG/DL" reported_type=""><description>HDL PARTICLES 7.5+/-0.2 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="7.021" sd="5.211" median="6.4" min="0" max="27.1"/><example count="254">0</example><example count="38">0.1</example><example count="34">3.8</example><example count="33">4.7</example><example count="31">3.2</example><example count="31">6.3</example><example count="31">8.4</example><example count="31">4.4</example><example count="30">0.2</example><example count="30">3.9</example></stats></total></variable><variable id="phv00024697.v6.p11.c1" var_name="HDLP1" calculated_type="decimal" units="MG/DL" reported_type=""><description>HDL PARTICLES 7.5+/-0.2 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="6.98" sd="5.236" median="6.3" min="0" max="27.1"/><example count="211">0</example><example count="29">0.1</example><example count="26">4.6</example><example count="25">8.4</example><example count="24">6.3</example><example count="24">6.9</example><example count="24">4.4</example><example count="24">4.7</example><example count="23">3.2</example><example count="23">1.3</example></stats></total></variable><variable id="phv00024697.v6.p11.c2" var_name="HDLP1" calculated_type="decimal" units="MG/DL" reported_type=""><description>HDL PARTICLES 7.5+/-0.2 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="7.093" sd="5.089" median="6.5" min="0" max="24.8"/><example count="43">0</example><example count="11">3.8</example><example count="11">8.1</example><example count="10">0.5</example><example count="10">3.9</example><example count="9">0.2</example><example count="9">7.8</example><example count="9">0.1</example><example count="9">12</example><example count="9">8.9</example></stats></total></variable><variable id="phv00024698.v6.p11" var_name="VLDLSZ" calculated_type="decimal" reported_type=""><description>WEIGHTED AVERAGE FOR VLDL SIZE BASED ON MEASUREMENTS OF VLDLP1 THROUGH VLDLP6, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="46.71" sd="9.494" median="44.5" min="32.1" max="90.4"/><example count="28">38.4</example><example count="28">44.5</example><example count="27">42.7</example><example count="26">40.7</example><example count="25">41.5</example><example count="25">41.3</example><example count="25">42.2</example><example count="23">38.6</example><example count="22">43</example><example count="22">42.1</example></stats></total></variable><variable id="phv00024698.v6.p11.c1" var_name="VLDLSZ" calculated_type="decimal" reported_type=""><description>WEIGHTED AVERAGE FOR VLDL SIZE BASED ON MEASUREMENTS OF VLDLP1 THROUGH VLDLP6, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="46.42" sd="9.429" median="44.1" min="32.1" max="90.4"/><example count="25">38.4</example><example count="23">42.7</example><example count="22">44.5</example><example count="21">40.7</example><example count="20">42.2</example><example count="19">43</example><example count="19">36.9</example><example count="18">41.5</example><example count="18">41.3</example><example count="18">42.1</example></stats></total></variable><variable id="phv00024698.v6.p11.c2" var_name="VLDLSZ" calculated_type="decimal" reported_type=""><description>WEIGHTED AVERAGE FOR VLDL SIZE BASED ON MEASUREMENTS OF VLDLP1 THROUGH VLDLP6, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="47.72" sd="9.683" median="45.6" min="32.7" max="86.6"/><example count="8">38.6</example><example count="8">44.1</example><example count="7">41.5</example><example count="7">42.3</example><example count="7">44.6</example><example count="7">47.1</example><example count="7">41.3</example><example count="7">40.5</example><example count="7">39.6</example><example count="6">43.7</example></stats></total></variable><variable id="phv00024699.v6.p11" var_name="LDLSZ" calculated_type="decimal" reported_type=""><description>WEIGHTED AVERAGE FOR LDL SIZE BASED ON MEASUREMENTS OF LDLP1 THROUGH LDLP6, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="20.86" sd="0.5645" median="21" min="19" max="22"/><example count="296">21.3</example><example count="294">21.2</example><example count="287">21.1</example><example count="279">21</example><example count="243">20.9</example><example count="233">21.4</example><example count="206">20.8</example><example count="183">20.7</example><example count="171">21.5</example><example count="141">20.6</example></stats></total></variable><variable id="phv00024699.v6.p11.c1" var_name="LDLSZ" calculated_type="decimal" reported_type=""><description>WEIGHTED AVERAGE FOR LDL SIZE BASED ON MEASUREMENTS OF LDLP1 THROUGH LDLP6, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="20.87" sd="0.5662" median="21" min="19" max="22"/><example count="225">21</example><example count="224">21.2</example><example count="224">21.1</example><example count="216">21.3</example><example count="186">21.4</example><example count="175">20.9</example><example count="168">20.8</example><example count="135">21.5</example><example count="127">20.7</example><example count="112">20.6</example></stats></total></variable><variable id="phv00024699.v6.p11.c2" var_name="LDLSZ" calculated_type="decimal" reported_type=""><description>WEIGHTED AVERAGE FOR LDL SIZE BASED ON MEASUREMENTS OF LDLP1 THROUGH LDLP6, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="20.83" sd="0.5581" median="20.9" min="19" max="21.9"/><example count="80">21.3</example><example count="67">21.2</example><example count="67">20.9</example><example count="63">21.1</example><example count="55">20.7</example><example count="52">21</example><example count="47">21.4</example><example count="38">20.8</example><example count="36">21.5</example><example count="28">20.6</example></stats></total></variable><variable id="phv00024700.v6.p11" var_name="HDLSZ" calculated_type="decimal" reported_type=""><description>WEIGHTED AVERAGE FOR HDL SIZE BASED ON MEASUREMENTS OF HDLP1 THROUGH HDLP6, EXAM 4</description><total><subject_profile><sex><male>1679</male><female>1748</female></sex></subject_profile><stats><stat n="3427" nulls="639" mean="9.153" sd="0.4848" median="9.1" min="7.8" max="11.5"/><example count="339">8.9</example><example count="304">9</example><example count="299">9.1</example><example count="269">8.8</example><example count="240">9.2</example><example count="223">9.3</example><example count="207">9.4</example><example count="206">8.7</example><example count="169">8.6</example><example count="161">9.6</example></stats></total></variable><variable id="phv00024700.v6.p11.c1" var_name="HDLSZ" calculated_type="decimal" reported_type=""><description>WEIGHTED AVERAGE FOR HDL SIZE BASED ON MEASUREMENTS OF HDLP1 THROUGH HDLP6, EXAM 4</description><total><subject_profile><sex><male>1304</male><female>1339</female></sex></subject_profile><stats><stat n="2643" nulls="487" mean="9.159" sd="0.4882" median="9.1" min="7.8" max="11.5"/><example count="272">8.9</example><example count="235">9.1</example><example count="235">9</example><example count="207">8.8</example><example count="169">9.2</example><example count="164">9.4</example><example count="163">9.3</example><example count="150">8.7</example><example count="131">8.6</example><example count="127">9.6</example></stats></total></variable><variable id="phv00024700.v6.p11.c2" var_name="HDLSZ" calculated_type="decimal" reported_type=""><description>WEIGHTED AVERAGE FOR HDL SIZE BASED ON MEASUREMENTS OF HDLP1 THROUGH HDLP6, EXAM 4</description><total><subject_profile><sex><male>369</male><female>404</female></sex></subject_profile><stats><stat n="773" nulls="151" mean="9.137" sd="0.4747" median="9.1" min="7.8" max="10.6"/><example count="70">9.2</example><example count="69">9</example><example count="66">8.9</example><example count="63">9.1</example><example count="59">8.8</example><example count="58">9.3</example><example count="56">8.7</example><example count="43">9.4</example><example count="37">9.5</example><example count="37">8.6</example></stats></total></variable><variable id="phv00024701.v6.p11" var_name="APOCIIIT" calculated_type="decimal" units="MG/DL" reported_type=""><description>APOLIPOPROTEIN CIII CONCENTRATION DETERMINED USING NEPHELOMETRIC ASSAY FROM WACO (MG/DL), EXAM 5</description><total><subject_profile><sex><male>1476</male><female>1679</female></sex></subject_profile><stats><stat n="3155" nulls="911" mean="17.23" sd="34.46" median="16" min="0" max="1934"/><example count="37">15.4</example><example count="36">13.1</example><example count="35">16</example><example count="35">18.2</example><example count="34">13.7</example><example count="34">14.9</example><example count="34">18.4</example><example count="34">15.8</example><example count="34">14.1</example><example count="33">15.6</example></stats></total></variable><variable id="phv00024701.v6.p11.c1" var_name="APOCIIIT" calculated_type="decimal" units="MG/DL" reported_type=""><description>APOLIPOPROTEIN CIII CONCENTRATION DETERMINED USING NEPHELOMETRIC ASSAY FROM WACO (MG/DL), EXAM 5</description><total><subject_profile><sex><male>1140</male><female>1299</female></sex></subject_profile><stats><stat n="2439" nulls="691" mean="16.43" sd="4.662" median="15.8" min="0" max="54.4"/><example count="31">15.4</example><example count="31">15.8</example><example count="30">13.1</example><example count="29">15.6</example><example count="28">16</example><example count="28">18.3</example><example count="28">14.8</example><example count="28">18.2</example><example count="27">15</example><example count="27">13.7</example></stats></total></variable><variable id="phv00024701.v6.p11.c2" var_name="APOCIIIT" calculated_type="decimal" units="MG/DL" reported_type=""><description>APOLIPOPROTEIN CIII CONCENTRATION DETERMINED USING NEPHELOMETRIC ASSAY FROM WACO (MG/DL), EXAM 5</description><total><subject_profile><sex><male>332</male><female>376</female></sex></subject_profile><stats><stat n="708" nulls="216" mean="19.99" sd="72.2" median="16.9" min="2.7" max="1934"/><example count="11">16.6</example><example count="11">17.7</example><example count="11">14.9</example><example count="10">12.5</example><example count="10">17.6</example><example count="10">16.9</example><example count="9">14.1</example><example count="9">13.8</example><example count="9">12.9</example><example count="8">11.4</example></stats></total></variable><variable id="phv00024702.v6.p11" var_name="APOA14" calculated_type="integer" units="MG/DL" reported_type=""><description>APOLIPOPROTEIN AI CONCENTRATION USING ELISA (MG/DL), EXAM 4</description><total><subject_profile><sex><male>1838</male><female>1906</female></sex></subject_profile><stats><stat n="3744" nulls="322" mean="143.6" sd="30.32" median="141" min="0" max="408"/><example count="79">134</example><example count="73">128</example><example count="69">131</example><example count="69">132</example><example count="65">140</example><example count="65">136</example><example count="63">154</example><example count="61">142</example><example count="61">150</example><example count="60">127</example></stats></total></variable><variable id="phv00024702.v6.p11.c1" var_name="APOA14" calculated_type="integer" units="MG/DL" reported_type=""><description>APOLIPOPROTEIN AI CONCENTRATION USING ELISA (MG/DL), EXAM 4</description><total><subject_profile><sex><male>1433</male><female>1476</female></sex></subject_profile><stats><stat n="2909" nulls="221" mean="143.7" sd="30.34" median="141" min="0" max="408"/><example count="63">134</example><example count="60">132</example><example count="57">131</example><example count="51">136</example><example count="51">128</example><example count="51">156</example><example count="50">154</example><example count="49">140</example><example count="48">129</example><example count="48">150</example></stats></total></variable><variable id="phv00024702.v6.p11.c2" var_name="APOA14" calculated_type="integer" units="MG/DL" reported_type=""><description>APOLIPOPROTEIN AI CONCENTRATION USING ELISA (MG/DL), EXAM 4</description><total><subject_profile><sex><male>399</male><female>425</female></sex></subject_profile><stats><stat n="824" nulls="100" mean="143.3" sd="29.61" median="140.5" min="0" max="282"/><example count="21">128</example><example count="18">139</example><example count="17">143</example><example count="17">142</example><example count="16">127</example><example count="16">140</example><example count="16">134</example><example count="15">149</example><example count="14">162</example><example count="14">126</example></stats></total></variable><variable id="phv00024703.v6.p11" var_name="APOB4" calculated_type="integer" units="MG/DL" reported_type=""><description>APOLIPOPPROTEIN B CONCENTRATION USING ELISA (MG/DL), EXAM 4</description><total><subject_profile><sex><male>1838</male><female>1906</female></sex></subject_profile><stats><stat n="3744" nulls="322" mean="99.23" sd="26.43" median="98" min="0" max="272"/><example count="84">88</example><example count="74">92</example><example count="73">98</example><example count="72">90</example><example count="70">102</example><example count="68">94</example><example count="66">100</example><example count="66">112</example><example count="66">108</example><example count="63">84</example></stats></total></variable><variable id="phv00024703.v6.p11.c1" var_name="APOB4" calculated_type="integer" units="MG/DL" reported_type=""><description>APOLIPOPPROTEIN B CONCENTRATION USING ELISA (MG/DL), EXAM 4</description><total><subject_profile><sex><male>1433</male><female>1476</female></sex></subject_profile><stats><stat n="2909" nulls="221" mean="98.32" sd="26.09" median="96" min="0" max="272"/><example count="66">88</example><example count="60">92</example><example count="56">94</example><example count="55">84</example><example count="55">98</example><example count="54">90</example><example count="54">112</example><example count="53">108</example><example count="50">102</example><example count="50">100</example></stats></total></variable><variable id="phv00024703.v6.p11.c2" var_name="APOB4" calculated_type="integer" units="MG/DL" reported_type=""><description>APOLIPOPPROTEIN B CONCENTRATION USING ELISA (MG/DL), EXAM 4</description><total><subject_profile><sex><male>399</male><female>425</female></sex></subject_profile><stats><stat n="824" nulls="100" mean="102.6" sd="26.92" median="102" min="0" max="236"/><example count="20">102</example><example count="18">90</example><example count="18">104</example><example count="18">98</example><example count="18">110</example><example count="18">88</example><example count="16">106</example><example count="15">100</example><example count="15">99</example><example count="15">105</example></stats></total></variable><variable id="phv00024704.v6.p11" var_name="RLP_C" calculated_type="decimal" units="MG/DL" reported_type=""><description>REMNANT LIKE PARTICLES MEASURED USING SELECTIVE IMMUNOSEPARATION OF LIPOPROTEINS USING THE OTSHUKA KIT. EXPRESSED AS CHOLESTEROL IN MG/DL, EXAM 4</description><total><subject_profile><sex><male>1517</male><female>1575</female></sex></subject_profile><stats><stat n="3092" nulls="974" mean="8.098" sd="6.523" median="6.522" min="3.583" max="164.2"/><example count="2">6.66001</example><example count="2">6.40891</example><example count="2">5.93021</example><example count="2">5.47159</example><example count="2">5.72746</example><example count="2">4.91489</example><example count="1">5.09565</example><example count="1">6.34522</example><example count="1">21.40333</example><example count="1">5.36809</example></stats></total></variable><variable id="phv00024704.v6.p11.c1" var_name="RLP_C" calculated_type="decimal" units="MG/DL" reported_type=""><description>REMNANT LIKE PARTICLES MEASURED USING SELECTIVE IMMUNOSEPARATION OF LIPOPROTEINS USING THE OTSHUKA KIT. EXPRESSED AS CHOLESTEROL IN MG/DL, EXAM 4</description><total><subject_profile><sex><male>1183</male><female>1202</female></sex></subject_profile><stats><stat n="2385" nulls="745" mean="7.977" sd="6.349" median="6.454" min="3.583" max="164.2"/><example count="2">6.40891</example><example count="2">5.93021</example><example count="2">5.72746</example><example count="1">5.09565</example><example count="1">6.34522</example><example count="1">21.40333</example><example count="1">6.87108</example><example count="1">10.38071</example><example count="1">5.42368</example><example count="1">6.41764</example></stats></total></variable><variable id="phv00024704.v6.p11.c2" var_name="RLP_C" calculated_type="decimal" units="MG/DL" reported_type=""><description>REMNANT LIKE PARTICLES MEASURED USING SELECTIVE IMMUNOSEPARATION OF LIPOPROTEINS USING THE OTSHUKA KIT. EXPRESSED AS CHOLESTEROL IN MG/DL, EXAM 4</description><total><subject_profile><sex><male>328</male><female>368</female></sex></subject_profile><stats><stat n="696" nulls="228" mean="8.511" sd="7.117" median="6.719" min="4.349" max="130.1"/><example count="1">5.36809</example><example count="1">4.89902</example><example count="1">11.03978</example><example count="1">5.90508</example><example count="1">5.43599</example><example count="1">5.47194</example><example count="1">8.20807</example><example count="1">11.86615</example><example count="1">4.91002</example><example count="1">5.04308</example></stats></total></variable><variable id="phv00024705.v6.p11" var_name="RLP_TG" calculated_type="decimal" units="MG/DL" reported_type=""><description>REMNANT LIKE PARTICLES MEASURED USING SELECTIVE IMMUNOSEPARATION OF LIPOPROTEINS USING THE OTSHUKA KIT. EXPRESSED AS TRIGLYCERIDES IN MG/DL, EXAM 4</description><total><subject_profile><sex><male>1493</male><female>1501</female></sex></subject_profile><stats><stat n="2994" nulls="1072" mean="28.34" sd="58.21" median="16.42" min="3.744" max="1906"/><example count="3">13.759</example><example count="3">12.513</example><example count="3">12.609</example><example count="3">24.905</example><example count="3">11.975</example><example count="2">9.272</example><example count="2">23.782</example><example count="2">15.361</example><example count="2">14.691</example><example count="2">10.602</example></stats></total></variable><variable id="phv00024705.v6.p11.c1" var_name="RLP_TG" calculated_type="decimal" units="MG/DL" reported_type=""><description>REMNANT LIKE PARTICLES MEASURED USING SELECTIVE IMMUNOSEPARATION OF LIPOPROTEINS USING THE OTSHUKA KIT. EXPRESSED AS TRIGLYCERIDES IN MG/DL, EXAM 4</description><total><subject_profile><sex><male>1163</male><female>1140</female></sex></subject_profile><stats><stat n="2303" nulls="827" mean="27.75" sd="58.88" median="16.21" min="3.823" max="1906"/><example count="3">13.759</example><example count="3">12.513</example><example count="3">12.609</example><example count="2">9.272</example><example count="2">19.474</example><example count="2">12.673</example><example count="2">17.803</example><example count="2">14.691</example><example count="2">39.239</example><example count="2">10.602</example></stats></total></variable><variable id="phv00024705.v6.p11.c2" var_name="RLP_TG" calculated_type="decimal" units="MG/DL" reported_type=""><description>REMNANT LIKE PARTICLES MEASURED USING SELECTIVE IMMUNOSEPARATION OF LIPOPROTEINS USING THE OTSHUKA KIT. EXPRESSED AS TRIGLYCERIDES IN MG/DL, EXAM 4</description><total><subject_profile><sex><male>324</male><female>356</female></sex></subject_profile><stats><stat n="680" nulls="244" mean="30.44" sd="56.32" median="17.16" min="3.744" max="1038"/><example count="2">15.706</example><example count="2">12.126</example><example count="2">10.908</example><example count="1">17.906</example><example count="1">13.009</example><example count="1">208.28</example><example count="1">22.54</example><example count="1">19.596</example><example count="1">117.921</example><example count="1">18.681</example></stats></total></variable><variable id="phv00024706.v6.p11" var_name="APOESER5" calculated_type="decimal" units="MG/DL" reported_type=""><description>APOE CONCENTRATIONS IN MG/DL USING IMMUNOCHEMICAL TECHNIQUE BY SERVIA, EXAM 5</description><total><subject_profile><sex><male>1364</male><female>1513</female></sex></subject_profile><stats><stat n="2877" nulls="1189" mean="10.1" sd="4.739" median="9.22" min="0" max="33.06"/><example count="9">8.24</example><example count="9">8.03</example><example count="8">7.59</example><example count="8">7.08</example><example count="8">9.8</example><example count="7">9.22</example><example count="7">6.71</example><example count="7">10.92</example><example count="7">10.34</example><example count="7">7.49</example></stats></total></variable><variable id="phv00024706.v6.p11.c1" var_name="APOESER5" calculated_type="decimal" units="MG/DL" reported_type=""><description>APOE CONCENTRATIONS IN MG/DL USING IMMUNOCHEMICAL TECHNIQUE BY SERVIA, EXAM 5</description><total><subject_profile><sex><male>1073</male><female>1182</female></sex></subject_profile><stats><stat n="2255" nulls="875" mean="10.14" sd="4.731" median="9.29" min="0" max="33.06"/><example count="8">8.24</example><example count="8">7.59</example><example count="8">7.08</example><example count="7">7.49</example><example count="7">8.03</example><example count="6">7.84</example><example count="6">6.71</example><example count="6">6.38</example><example count="6">5.44</example><example count="6">6.18</example></stats></total></variable><variable id="phv00024706.v6.p11.c2" var_name="APOESER5" calculated_type="decimal" units="MG/DL" reported_type=""><description>APOE CONCENTRATIONS IN MG/DL USING IMMUNOCHEMICAL TECHNIQUE BY SERVIA, EXAM 5</description><total><subject_profile><sex><male>289</male><female>328</female></sex></subject_profile><stats><stat n="617" nulls="307" mean="9.967" sd="4.774" median="9.04" min="0" max="32.34"/><example count="4">8.26</example><example count="3">7.2</example><example count="3">8.38</example><example count="3">8.77</example><example count="3">9.95</example><example count="3">3.97</example><example count="3">5.53</example><example count="3">6.14</example><example count="3">10.34</example><example count="3">9.46</example></stats></total></variable></data_table>
